UMP Healthcare Holdings Limited (00722.HK) Financial Statements

Income statement

Metric	TTM	2026	2025	2024	2023
Revenue
Total Revenue	1.4B	717.0M	727.4M	748.5M	727.8M
Cost of Revenue	529.4M	342.0M	236.7M	56.2M	225.1M
Gross Profit	915.1M	375.0M	490.6M	692.3M	502.7M
Operating Expenses
R&D Expense	—	—	—	—	—
SG&A Expense	685.1M	445.6M	272.4M	269.4M	269.4M
General & Admin Expense	390.9M	—	257.0M	269.4M	255.4M
Selling & Marketing Expense	24.2M	—	15.4M	—	14.0M
Other Expenses	—	—	—	18.1M	—
Total Operating Expenses	685.1M	445.6M	272.4M	287.5M	269.4M
Cost and Expenses	1.2B	787.5M	509.1M	653.1M	494.5M
Operating Income (EBIT)	230.0M	(70.6M)	218.2M	95.4M	66.8M
Non-Operating
Interest Income	9.4M	4.4M	5.0M	5.5M	3.4M
Interest Expense	13.6M	6.3M	7.3M	6.9M	5.7M
Net Interest Income	(3.7M)	(1.9M)	(1.9M)	(1.4M)	(2.3M)
Other Non-Op Income/Expense	(254.2M)	5.8M	(177.7M)	(54.8M)	(2.4M)
Non-Operating Income (excl Interest)	261.9M	—	180.7M	47.8M	59.3M
EBT (Pre-Tax Income)	(24.3M)	(64.8M)	40.5M	40.6M	64.4M
Income Tax Expense	16.6M	8.0M	8.6M	5.4M	8.6M
Bottom Line
Net Income	(43.2M)	(74.6M)	31.4M	40.6M	60.5M
Earnings from Cont. Ops	(40.8M)	(72.7M)	31.9M	35.2M	55.7M
Earnings from Discont. Ops	—	—	—	—	—
Bottom Line Net Income	(43.2M)	(74.6M)	31.4M	40.6M	60.5M
Per Share
Basic EPS	(HK$0.06)	(HK$0.09)	HK$0.04	HK$0.05	HK$0.08
Diluted EPS	(HK$0.06)	(HK$0.09)	HK$0.04	HK$0.05	HK$0.08
Revenue Per Share	HK$1.83	HK$0.90	HK$0.92	HK$0.94	HK$0.92
Shares
Basic Shares Outstanding	789.7M	792.4M	789.2M	799.5M	790.0M
Diluted Shares Outstanding	789.7M	792.4M	789.2M	799.5M	790.0M
Profitability Metrics
EBITDA	171.4M	27.0M	143.3M	162.0M	178.2M
D&A	203.3M	97.5M	105.8M	113.8M	103.9M
EBIT	(31.9M)	(70.6M)	37.5M	47.6M	69.6M

As reported, in the filing currency · TTM sums the four latest quarters; MRQ is the latest quarter · Negatives in parentheses; a dash is a line the filing does not carry · Data as of Jun 1, 2026